Deoxyribonuclease 1 Q222R single nucleotide polymorphism and long-term mortality after acute myocardial infarction
Basic Research in Cardiology · 2021-12 · 116 (1)
DOI: 10.1007/s00395-021-00864-w ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Basic Research in Cardiology, online erschienen am 23.04.2021. Verfasst von Thomas M Hofbauer und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Division of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Ludwig-Maximilians-Universität, Bürgermeister-Fonds.
Abstract (Originalsprache)
Upon activation, neutrophils release neutrophil extracellular traps (NETs), which contribute to circulating DNA burden and thrombosis, including ST-segment elevation myocardial infarction (STEMI). Deoxyribonuclease (DNase) 1 degrades circulating DNA and NETs. Lower DNase activity correlates with NET burden and infarct size. The DNase 1 Q222R single nucleotide polymorphism (SNP), impairing DNase 1 function, is linked with myocardial infarction. We assessed whether the Q222R SNP is connected to increased NET burden in STEMI and influences long-term outcomes. We enrolled 711 STEMI patients undergoing primary percutaneous coronary intervention (pPCI), and 1422 controls. Genotyping was performed for DNase 1 Q222R SNP. DNase activity, double-stranded (ds)DNA and citrullinated histone H3 were determined in culprit site and peripheral plasma during pPCI. The association of the Q222R variant on cardiovascular and all-cause mortality was assessed by multivariable Cox regression adjusted for cardiovascular risk factors. Homozygous Q222R DNase 1 variant was present in 64 (9.0%) STEMI patients, at the same frequency as in controls. Patients homozygous for Q222R displayed less DNase activity and increased circulating DNA burden. In overall patients, median survival was 60 months. Homozygous Q222R variant was independently associated with cardiovascular and all-cause mortality after STEMI. dsDNA/DNase ratio independently predicted cardiovascular and all-cause mortality. These findings highlight that the Q222R DNase 1 SNP is associated with increased NET burden and decreased compensatory DNase activity, and may serve as an independent risk factor for poor outcome after STEMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Division of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
- IBE (Institute for Medical Information Processing, Biometry, and Epidemiology), Faculty of Medicine, LMU Munich, Munich, Germany.
- Department of Internal Medicine I (Cardiology), Hospital of the Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
- Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University, Mainz, Germany.
- Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Förderung
- Austrian Science Fund
- Ludwig-Maximilians-Universität
- Bürgermeister-Fonds
- Bundesministerium für Bildung und Forschung
- State of Bavaria, Germany
- Medical University of Vienna
Zitieren
APA
Hofbauer, T. M., Mangold, A., Ondracek, A. S., Panzenböck, A., Scherz, T., Müller, J., Distelmaier, K., Seidl, V., Kastl, S., Müller-Nurasyid, M., Peters, A., Strauch, K., Winker, R., Wohlschläger-Krenn, E., Nistler, S., & Lang, I. M. (2021). Deoxyribonuclease 1 Q222R single nucleotide polymorphism and long-term mortality after acute myocardial infarction. Basic Research in Cardiology, 116(1). https://doi.org/10.1007/s00395-021-00864-w
Vancouver
Hofbauer TM, Mangold A, Ondracek AS, Panzenböck A, Scherz T, Müller J, et al. Deoxyribonuclease 1 Q222R single nucleotide polymorphism and long-term mortality after acute myocardial infarction. Basic Research in Cardiology. 2021;116(1). doi:10.1007/s00395-021-00864-w
BibTeX
@article{Hofbauer2021,
author = {Hofbauer, Thomas M and Mangold, Andreas and Ondracek, Anna S and Panzenböck, Adelheid and Scherz, Thomas and Müller, Julian and Distelmaier, Klaus and Seidl, Veronika and Kastl, Stefan and Müller-Nurasyid, Martina and Peters, Annette and Strauch, Konstantin and Winker, Robert and Wohlschläger-Krenn, Evelyne and Nistler, Sonja and Lang, Irene M},
title = {Deoxyribonuclease 1 Q222R single nucleotide polymorphism and long-term mortality after acute myocardial infarction},
journal = {Basic Research in Cardiology},
year = {2021},
volume = {116},
number = {1},
doi = {10.1007/s00395-021-00864-w}
}
EUVIMED